Drug Type Small molecule drug |
Synonyms NVPQAV-680, QAV 680, QAV680 |
Target |
Mechanism CRTH2 antagonists(Prostaglandin D2 receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H18N2O4S |
InChIKeyYOPFAMROKXHVCQ-UHFFFAOYSA-N |
CAS Registry872365-16-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | US | 01 Mar 2010 | |
Asthma | Phase 2 | DE | 01 Mar 2010 | |
Asthma | Phase 2 | RU | 01 Mar 2010 | |
Persistent asthma | Phase 2 | DE | 01 Dec 2008 | |
Persistent asthma | Phase 2 | IN | 01 Dec 2008 | |
Rhinitis, Allergic, Seasonal | Phase 2 | CA | 01 Sep 2008 |